Combined use of enalapril and losartan to reduce proteinuria: a question of safety. [electronic resource]
- American journal of kidney diseases : the official journal of the National Kidney Foundation Jan 2002
- 209-11 p. digital
Publication Type: Comment; Letter
1523-6838
10.1053/ajkd.2002.31031 doi
Adolescent Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors--adverse effects Child Child, Preschool Drug Therapy, Combination Enalapril--adverse effects Humans Hyperkalemia--chemically induced Losartan--adverse effects Proteinuria--prevention & control Receptor, Angiotensin, Type 1